We examined the percentage of CD11b+CD14+HLA-DR− myeloid cells and the levels of IL-6 in the peripheral blood of 50 patients with esophageal SCC and 12 healthy controls. The gene discussed is CD14; the disease is esophageal squamous cell carcinoma.